Aberdeen’s Akus on the struggles facing healthcare, biotech investors
Jason Akus, Head of Healthcare Investing for Aberdeen Investments, says that current conditions for healthcare and biotech investing are making for "one of the most challenging, difficult and dislocated environments I've seen." While trades in technology, artificial intelligence and...
Answers on cash-flow generation, tax-loss selling and more
John Cole Scott, executive chairman of the Active Investment Company Alliance returns to The NAVigator to answer audience questions about some of the nuts and bolts of closed-end fund investing, covering tax-loss selling and where to expect good opportunities this year...
Bulldog Investors’ Goldstein sees trouble ahead for activist investors
Phillip Goldstein, co-founder of the Bulldog Investors hedge fund and a legendary activist investor in the closed-end fund space said at the Active Investment Company Alliance Boot Camp and Conference in New York City that he fears for the future of...


